By architecting DRAGEN™ from the ground up to be a highly optimized, reconfigurable platform, it is able to achieve NGS data processing speeds orders of magnitude faster than any other methods – without any compromises.
By incorporating multiple analyses and not resorting to heuristic methods like all other NGS data analysis methods, DRAGEN™ produces the highest possible accuracy for clinical interpretation and treatment guidance.
The reconfigurable DRAGEN™ Bio-IT Platform can be loaded with highly optimized algorithms for many different NGS secondary analysis pipelines such as Whole Genome or Exome, RNAseq, Methylome, Microbiome and Cancer.
Revolutionizing Genome Sequencing Analysis
At Edico Genome, we’re helping usher in the new era of personalized medicine by enabling a fundamental change in healthcare with customized treatments and data-driven insights tailored to the individual. At the heart of personalized medicine, DNA sequencing technology is advancing at an even more rapid pace than the cell phone revolution. By increasing the speed and accuracy for NGS data analysis like whole genome sequencing (WGS), our computing platform makes it easier to discover links between DNA sequence variations and human disease.